From Ars Technica
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
TechStar AsiaIdeas without bordersAsia & global innovationTechStar AsiaIdeas without bordersAsia & global innovationFrom Ars Technica
The risk appears small and data is mixed, but FDA wants patients to be aware.